KAIST Gives Antibodies “Eyes” to Detect Cancer, Targeting Cancer Mutations Inside Cells (IMAGE)
Caption
Members of the research team. From left: SangPhil Ahn, researcher at TheraZyne, Inc. (KAIST alumnus); Dr. Bo-Seong Jeong of TheraZyne, Inc. (KAIST alumnus and co-corresponding author); and Byung-Ha Oh, CEO of TheraZyne, Inc. and professor at the KAIST Graduate School of Engineering Biology.
Credit
KAIST
Usage Restrictions
No
License
Licensed content